| Ad Title: |
ChemoRadiotherapy in Patients with Limited Small Cell Lung Cancer |
| Study Title: |
CALGB 30610/RTOG 0538 Phase III Comparison of Thoracic Radiotheraphy Regimens With Cisplatin And Etoposide In Limited Small Cell Lung Cancer |
| Protocol Number: |
102008-025 |
| Department(s) involved in the Study: |
Radiation Oncology, Simmons Comprehensive Cancer Center
|
| Purpose of the Study: |
To determine whether administering high dose thoracic radiotherapy, 70 Gy (2 Gy once-daily over 7 weeks) or 61.2 Gy (1.8 Gy once-daily for 16 days followed by 1.8 Gy twice-daily for 9 days), will improve median and 2-year survival compared with 45 Gy
(1.5 Gy twice-daily over 3 weeks) in patients with limited stage small cell lung cancer
|
| Participant Eligibility: |
Histologically or cytologically documented small cell lung cancer. Contact study coordinator for more information. |
| Disease/Condition Under Study: |
Limited Stage Small Cell Lung Cancer |
| Cancer Related Study: |
No
|
| Study Drug(s): |
|
| Study Device(s): |
|
| Study Doctor: |
Dr. Hak Choy |
| Location of Study: |
|
Sites
|
Recruiting at this Site
|
|
Parkland Memorial Hospital
|
Yes
|
|
UT Southwestern University Hospitals St. Paul Building
|
Yes
|
|
UT Southwestern University Hospitals Zale Lipshy Building
|
Yes
|
|
UT Southwestern Moncrief Cancer Center, Richardson Regional Medical Center
|
Yes
|
|
| Contact Phone: |
214-648-1631 |
| Email: |
laurin.loudat@Utsouthwestern.Edu |
| Other Information: |
|
| Website Keywords: |
Lung Cancer, Oncology, Therapeutic Radiology
|
| Medical Keywords: |
CALGB 30610/RTOG 0538, chemotherapy, Cisplatin and Etoposide, IMRT, limited stage small cell lung cancer, thoracic intensity modulated radiation therapy, Thoracic Radiotherapy
|
